Drug Delivery Technology Development in Canada
Material type:
ArticlePublication details: MDPI - Multidisciplinary Digital Publishing Institute 2019Description: 1 electronic resource (352 p.)Content type: - text
- computer
- online resource
- 9783039280049
- 9783039280056
- Medicine
- 3D spheroid
- Canada
- DOX-Vit D
- EGFR-targeted therapy
- GE11 peptide
- HAV6 cadherin peptide
- HIF-1
- MG63
- Metaplex
- ROESY NMR spectroscopy
- STAT3
- TNO gastrointestinal model
- Vitamin D
- adenanthin
- amphotericin B
- antibodies
- bacteriophage
- bioaccessibility
- biodistribution
- biological barriers
- biologicals
- blood-brain barrier
- blood-brain barrier (BBB)
- cancer
- canola oil deodorizer distillate
- cationic gemini surfactant
- child friendly formulation
- chronotherapy
- circadian clock
- cisplatin
- clinical trials
- co-delivery
- combination therapy
- controlled drug delivery
- developing world
- dissolution
- doxorubicin
- drug delivery
- drug delivery systems
- drug development
- drug discovery
- drug-resistant melanoma
- emulsion
- encapsulation
- flavonoids
- formulation and dosage form development
- fungal infections
- gambogic acid
- gastrointestinal simulator
- head and neck squamous cell carcinoma
- hypoxia-induced chemoresistance
- inclusion complex
- innovation
- intra-arterial chemotherapy
- lipid nanoparticles
- liposome
- liposomes
- loading gradients
- magnetic fields
- magnetic resonanc
Open Access Unrestricted online access star
Canada continues to have a rich history of ground-breaking research in drug delivery within academic institutions, pharmaceutical industry and the biotechnology community.
Creative Commons Licence cc by-nc-nd cc https://creativecommons.org/licenses/by-nc-nd/4.0/
eng
Freely available e-book